Revenio Group Oyj (HEL: REG1V)

Market Cap	769.69M
Revenue (ttm)	102.49M
Net Income (ttm)	19.11M
Shares Out	26.60M
EPS (ttm)	0.72
PE Ratio	40.34
Forward PE	32.07
Dividend	0.38 (1.35%)
Ex-Dividend Date	Apr 5, 2024

Volume	22,645
Average Volume	22,996
Open	28.44
Previous Close	28.18
Day's Range	28.44 - 29.36
52-Week Range	23.36 - 35.84
Beta	1.35
RSI	60.92
Earnings Date	Feb 13, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 207
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2023, Revenio Group Oyj's revenue was 96.79 million, a decrease of -0.46% compared to the previous year's 97.23 million. Earnings were 19.11 million, a decrease of -12.15%.